EGFR and lymphoma: Previous studies indicate that the SLIT/ROBO pathway acts as master regulator for multiple oncogenic signalling pathways including the CD20, mTOR, VEGF and EGFR pathways in several cancer types including lung cancer, colon cancer and lymphoma [33].